

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cell adhesion mediated by integrin (GO:0033627) | 5.34122763 |
| 2 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 5.23637099 |
| 3 | chondrocyte proliferation (GO:0035988) | 5.16851614 |
| 4 | response to peptidoglycan (GO:0032494) | 4.94115215 |
| 5 | hemidesmosome assembly (GO:0031581) | 4.70718547 |
| 6 | atrioventricular valve morphogenesis (GO:0003181) | 4.64235289 |
| 7 | * wound healing, spreading of epidermal cells (GO:0035313) | 4.57437274 |
| 8 | mesodermal cell differentiation (GO:0048333) | 4.31614646 |
| 9 | skin morphogenesis (GO:0043589) | 4.30800845 |
| 10 | * wound healing, spreading of cells (GO:0044319) | 4.22127021 |
| 11 | cellular extravasation (GO:0045123) | 4.12434994 |
| 12 | desmosome organization (GO:0002934) | 4.00143475 |
| 13 | cellular response to arsenic-containing substance (GO:0071243) | 3.95533475 |
| 14 | endodermal cell differentiation (GO:0035987) | 3.93983926 |
| 15 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.93880243 |
| 16 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.91019836 |
| 17 | protein localization to endosome (GO:0036010) | 3.90802613 |
| 18 | positive regulation of osteoblast proliferation (GO:0033690) | 3.84404442 |
| 19 | collagen fibril organization (GO:0030199) | 3.74798295 |
| 20 | lung vasculature development (GO:0060426) | 3.69224487 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 3.57670654 |
| 22 | endothelial cell morphogenesis (GO:0001886) | 3.53633072 |
| 23 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.50615465 |
| 24 | positive regulation of astrocyte differentiation (GO:0048711) | 3.49398276 |
| 25 | positive regulation of p38MAPK cascade (GO:1900745) | 3.47782209 |
| 26 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.47043076 |
| 27 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.46973368 |
| 28 | membrane raft organization (GO:0031579) | 3.42707271 |
| 29 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.39688502 |
| 30 | cell-substrate junction assembly (GO:0007044) | 3.39376119 |
| 31 | lymphangiogenesis (GO:0001946) | 3.38367845 |
| 32 | oligosaccharide catabolic process (GO:0009313) | 3.36397649 |
| 33 | glycosphingolipid catabolic process (GO:0046479) | 3.36353418 |
| 34 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.31509181 |
| 35 | barbed-end actin filament capping (GO:0051016) | 3.27209794 |
| 36 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.27131054 |
| 37 | response to muramyl dipeptide (GO:0032495) | 3.26766624 |
| 38 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.22612831 |
| 39 | plasma membrane repair (GO:0001778) | 3.21767084 |
| 40 | pinocytosis (GO:0006907) | 3.21300070 |
| 41 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.20259145 |
| 42 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.15273651 |
| 43 | heart valve morphogenesis (GO:0003179) | 3.14017628 |
| 44 | negative regulation of fatty acid transport (GO:2000192) | 3.13500468 |
| 45 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.13222463 |
| 46 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.13171836 |
| 47 | endothelial cell chemotaxis (GO:0035767) | 3.10002732 |
| 48 | neural crest cell development (GO:0014032) | 3.08853420 |
| 49 | epithelial cell-cell adhesion (GO:0090136) | 3.08507750 |
| 50 | regulation of p38MAPK cascade (GO:1900744) | 3.08460177 |
| 51 | endocardial cushion development (GO:0003197) | 3.07345075 |
| 52 | regulation of mononuclear cell migration (GO:0071675) | 3.05484066 |
| 53 | positive regulation of extracellular matrix organization (GO:1903055) | 3.05055671 |
| 54 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.03664734 |
| 55 | endothelium development (GO:0003158) | 3.02466762 |
| 56 | glycolipid catabolic process (GO:0019377) | 2.99002862 |
| 57 | keratinocyte proliferation (GO:0043616) | 2.97715429 |
| 58 | negative regulation of interleukin-12 production (GO:0032695) | 2.95819502 |
| 59 | glial cell migration (GO:0008347) | 2.95729309 |
| 60 | positive regulation of odontogenesis (GO:0042482) | 2.95243655 |
| 61 | hypotonic response (GO:0006971) | 2.94496676 |
| 62 | fibroblast migration (GO:0010761) | 2.93831601 |
| 63 | angiogenesis involved in wound healing (GO:0060055) | 2.92550616 |
| 64 | cellular response to vitamin D (GO:0071305) | 2.92370972 |
| 65 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.91736502 |
| 66 | regulation of vitamin metabolic process (GO:0030656) | 2.91497504 |
| 67 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.90975904 |
| 68 | positive regulation of cartilage development (GO:0061036) | 2.90941410 |
| 69 | positive regulation of leukocyte degranulation (GO:0043302) | 2.89012732 |
| 70 | response to laminar fluid shear stress (GO:0034616) | 2.88895306 |
| 71 | response to gravity (GO:0009629) | 2.87506696 |
| 72 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.87437828 |
| 73 | lymph vessel development (GO:0001945) | 2.87096829 |
| 74 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.86515874 |
| 75 | mRNA transcription (GO:0009299) | 2.84676635 |
| 76 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.84420566 |
| 77 | basement membrane organization (GO:0071711) | 2.84295213 |
| 78 | interferon-gamma secretion (GO:0072643) | 2.83724997 |
| 79 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.83266063 |
| 80 | protein localization to cell surface (GO:0034394) | 2.83244134 |
| 81 | regulation of tight junction assembly (GO:2000810) | 2.82012118 |
| 82 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.78887806 |
| 83 | Notch signaling involved in heart development (GO:0061314) | 2.78875549 |
| 84 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.78009094 |
| 85 | glomerular visceral epithelial cell development (GO:0072015) | 2.77326484 |
| 86 | blood vessel endothelial cell migration (GO:0043534) | 2.77160582 |
| 87 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.76943329 |
| 88 | positive regulation of collagen biosynthetic process (GO:0032967) | 2.76574427 |
| 89 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.76547544 |
| 90 | chemical homeostasis within a tissue (GO:0048875) | 2.74236009 |
| 91 | negative regulation of interleukin-8 production (GO:0032717) | 2.73938367 |
| 92 | establishment of endothelial barrier (GO:0061028) | 2.73315906 |
| 93 | regulation of chemokine secretion (GO:0090196) | 2.73142594 |
| 94 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.70691953 |
| 95 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.68922651 |
| 96 | renal filtration (GO:0097205) | 2.68319741 |
| 97 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.67664162 |
| 98 | regulation of glomerular filtration (GO:0003093) | 2.65289904 |
| 99 | regulation of podosome assembly (GO:0071801) | 2.65125769 |
| 100 | monocyte chemotaxis (GO:0002548) | 2.64280902 |
| 101 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.64191423 |
| 102 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.64076750 |
| 103 | hippo signaling (GO:0035329) | 2.64030094 |
| 104 | regulation of plasminogen activation (GO:0010755) | 2.63453929 |
| 105 | response to progesterone (GO:0032570) | 2.63316456 |
| 106 | notochord development (GO:0030903) | 2.63054267 |
| 107 | blood vessel remodeling (GO:0001974) | 2.62255892 |
| 108 | positive regulation of endothelial cell migration (GO:0010595) | 2.60795689 |
| 109 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.59609772 |
| 110 | germinal center formation (GO:0002467) | 2.58877508 |
| 111 | regulation of cardioblast differentiation (GO:0051890) | 2.58807030 |
| 112 | granulocyte activation (GO:0036230) | 2.58215126 |
| 113 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.57469683 |
| 114 | positive regulation of collagen metabolic process (GO:0010714) | 2.57088955 |
| 115 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.56582767 |
| 116 | regulation of monocyte chemotaxis (GO:0090025) | 2.56548834 |
| 117 | stress fiber assembly (GO:0043149) | 2.56163455 |
| 118 | regulation of macrophage chemotaxis (GO:0010758) | 2.55783252 |
| 119 | regulation of collagen biosynthetic process (GO:0032965) | 2.55574803 |
| 120 | response to thyroid hormone (GO:0097066) | 2.55045316 |
| 121 | decidualization (GO:0046697) | 2.54412281 |
| 122 | surfactant homeostasis (GO:0043129) | 2.54379340 |
| 123 | response to fluid shear stress (GO:0034405) | 2.54351734 |
| 124 | collagen metabolic process (GO:0032963) | 2.53938409 |
| 125 | negative regulation of catenin import into nucleus (GO:0035414) | 2.53517524 |
| 126 | positive regulation of interleukin-6 production (GO:0032755) | 2.53355522 |
| 127 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.53321112 |
| 128 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.53259511 |
| 129 | negative regulation of lipid storage (GO:0010888) | 2.53043856 |
| 130 | apoptotic cell clearance (GO:0043277) | 2.52733386 |
| 131 | glomerular basement membrane development (GO:0032836) | 2.52386250 |
| 132 | neutrophil chemotaxis (GO:0030593) | 2.52130345 |
| 133 | positive regulation of stem cell differentiation (GO:2000738) | 2.52101514 |
| 134 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.51913052 |
| 135 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.51675359 |
| 136 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.51397368 |
| 137 | hyaluronan catabolic process (GO:0030214) | 2.51115842 |
| 138 | glomerular epithelial cell development (GO:0072310) | 2.51013257 |
| 139 | extracellular matrix disassembly (GO:0022617) | 2.50612608 |
| 140 | regulation of collagen metabolic process (GO:0010712) | 2.50385007 |
| 141 | substrate-dependent cell migration (GO:0006929) | 2.50017444 |
| 142 | ceramide catabolic process (GO:0046514) | 2.49776151 |
| 143 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.49304920 |
| 144 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.49294001 |
| 145 | regulation of interleukin-8 secretion (GO:2000482) | 2.49129107 |
| 146 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.48832421 |
| 147 | macrophage activation (GO:0042116) | 2.48760837 |
| 148 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.48042525 |
| 149 | dermatan sulfate biosynthetic process (GO:0030208) | 2.47994858 |
| 150 | regulation of chemokine biosynthetic process (GO:0045073) | 2.47700693 |
| 151 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.47284800 |
| 152 | cardiac epithelial to mesenchymal transition (GO:0060317) | 2.47050463 |
| 153 | negative regulation of anoikis (GO:2000811) | 2.46587277 |
| 154 | negative regulation of stem cell proliferation (GO:2000647) | 2.45954074 |
| 155 | * positive regulation of epithelial cell migration (GO:0010634) | 2.45632618 |
| 156 | granulocyte chemotaxis (GO:0071621) | 2.44880666 |
| 157 | neutrophil migration (GO:1990266) | 2.44751495 |
| 158 | regulation of leukocyte degranulation (GO:0043300) | 2.42835769 |
| 159 | cellular copper ion homeostasis (GO:0006878) | 2.42537126 |
| 160 | macrophage activation involved in immune response (GO:0002281) | 2.42524424 |
| 161 | regulation of mast cell degranulation (GO:0043304) | 2.42470361 |
| 162 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.39213620 |
| 163 | cellular response to zinc ion (GO:0071294) | 2.37522551 |
| 164 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.37112552 |
| 165 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.36717490 |
| 166 | regulation of interleukin-6 production (GO:0032675) | 2.36045847 |
| 167 | granulocyte migration (GO:0097530) | 2.35987787 |
| 168 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.35737742 |
| 169 | detection of molecule of bacterial origin (GO:0032490) | 2.33081742 |
| 170 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.32527555 |
| 171 | positive regulation of mast cell degranulation (GO:0043306) | 2.32527555 |
| 172 | cellular response to lipopolysaccharide (GO:0071222) | 2.31846396 |
| 173 | positive regulation of mast cell activation (GO:0033005) | 2.29658510 |
| 174 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.29103925 |
| 175 | regulation of macrophage cytokine production (GO:0010935) | 2.27526884 |
| 176 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.26734275 |
| 177 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.26211870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 9.91769956 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 6.28116810 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.41668536 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.17377174 |
| 5 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.74004130 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.12125130 |
| 7 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.88991923 |
| 8 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.69120197 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.63743733 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52611572 |
| 11 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.52059137 |
| 12 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.52059137 |
| 13 | CJUN_26792858_Chip-Seq_BT549_Human | 2.44946499 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35220682 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.30240906 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.27894467 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.25207969 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.24029758 |
| 19 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.20873642 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.09347831 |
| 21 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.06714467 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.98461046 |
| 23 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.89028554 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.88450828 |
| 25 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.86886698 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.86488327 |
| 27 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.85323535 |
| 28 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.84934865 |
| 29 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.84799600 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.84191096 |
| 31 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.83142764 |
| 32 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.82785359 |
| 33 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.80469978 |
| 34 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.79419172 |
| 35 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.79201028 |
| 36 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.69747597 |
| 37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.69738592 |
| 38 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.65901959 |
| 39 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.65226454 |
| 40 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.64045137 |
| 41 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.61381142 |
| 42 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.61381142 |
| 43 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.61307150 |
| 44 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.61218586 |
| 45 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.59332024 |
| 46 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.57356318 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57295698 |
| 48 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.57025106 |
| 49 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.55506400 |
| 50 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.55345094 |
| 51 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.51428338 |
| 52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.50692704 |
| 53 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.49900521 |
| 54 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.45605901 |
| 55 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.44536442 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.42345538 |
| 57 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.40438363 |
| 58 | TP53_16413492_ChIP-PET_HCT116_Human | 1.39492375 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.38222985 |
| 60 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.36951444 |
| 61 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.36666534 |
| 62 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.36165790 |
| 63 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.36128694 |
| 64 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.34302354 |
| 65 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.34152762 |
| 66 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.32921553 |
| 67 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.31871843 |
| 68 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.30827950 |
| 69 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28252013 |
| 70 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.26834926 |
| 71 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.26591368 |
| 72 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.26578873 |
| 73 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22196118 |
| 74 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.21627430 |
| 75 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.21557485 |
| 76 | SPI1_23127762_ChIP-Seq_K562_Human | 1.20456570 |
| 77 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.18167481 |
| 78 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.16503435 |
| 79 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15872292 |
| 80 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15737989 |
| 81 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15585751 |
| 82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15333052 |
| 83 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.13501254 |
| 84 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.12322298 |
| 85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10573962 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09590593 |
| 87 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09293605 |
| 88 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.08905148 |
| 89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08545833 |
| 90 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.07159049 |
| 91 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06814950 |
| 92 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05410945 |
| 93 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.04037414 |
| 94 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.02478973 |
| 95 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01906888 |
| 96 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01811790 |
| 97 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.99777930 |
| 98 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.99134242 |
| 99 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.98887209 |
| 100 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98772918 |
| 101 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98235506 |
| 102 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96545491 |
| 103 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95881197 |
| 104 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95605262 |
| 105 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.94562017 |
| 106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94283960 |
| 107 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94160009 |
| 108 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.94100372 |
| 109 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.93485084 |
| 110 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.92857929 |
| 111 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.91963237 |
| 112 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.91582977 |
| 113 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90625065 |
| 114 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89165878 |
| 115 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88198368 |
| 116 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88172288 |
| 117 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.88031537 |
| 118 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.86213541 |
| 119 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.86213541 |
| 120 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.85868764 |
| 121 | KDM2B_26808549_Chip-Seq_K562_Human | 0.85627180 |
| 122 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84758273 |
| 123 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.84666017 |
| 124 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.83753116 |
| 125 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.82397694 |
| 126 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.82054463 |
| 127 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.81815749 |
| 128 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.80667083 |
| 129 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80569722 |
| 130 | RXR_22108803_ChIP-Seq_LS180_Human | 0.79979485 |
| 131 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.78467239 |
| 132 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75946841 |
| 133 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.74207263 |
| 134 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.73981170 |
| 135 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.72079010 |
| 136 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.71864027 |
| 137 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71727675 |
| 138 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.70220001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.85178666 |
| 2 | MP0004272_abnormal_basement_membrane | 3.53558266 |
| 3 | MP0009840_abnormal_foam_cell | 3.39317816 |
| 4 | MP0005623_abnormal_meninges_morphology | 3.26201367 |
| 5 | MP0005275_abnormal_skin_tensile | 3.25664628 |
| 6 | MP0003566_abnormal_cell_adhesion | 3.11263650 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.11237614 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 2.98565801 |
| 9 | MP0003279_aneurysm | 2.96557136 |
| 10 | MP0003941_abnormal_skin_development | 2.87705018 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.73510557 |
| 12 | MP0001958_emphysema | 2.70320524 |
| 13 | MP0004510_myositis | 2.65777234 |
| 14 | MP0003436_decreased_susceptibility_to | 2.63862212 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.57201673 |
| 16 | MP0010368_abnormal_lymphatic_system | 2.55520847 |
| 17 | MP0005503_abnormal_tendon_morphology | 2.53401219 |
| 18 | MP0005023_abnormal_wound_healing | 2.43714311 |
| 19 | MP0009379_abnormal_foot_pigmentation | 2.38677898 |
| 20 | MP0008004_abnormal_stomach_pH | 2.32140209 |
| 21 | MP0003091_abnormal_cell_migration | 2.31747136 |
| 22 | MP0003075_altered_response_to | 2.29488605 |
| 23 | MP0009384_cardiac_valve_regurgitation | 2.28244685 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.03977366 |
| 25 | MP0001879_abnormal_lymphatic_vessel | 2.01510201 |
| 26 | MP0003828_pulmonary_edema | 1.97701875 |
| 27 | MP0001542_abnormal_bone_strength | 1.96504568 |
| 28 | MP0006054_spinal_hemorrhage | 1.96162987 |
| 29 | MP0002419_abnormal_innate_immunity | 1.94171652 |
| 30 | MP0002332_abnormal_exercise_endurance | 1.93428128 |
| 31 | MP0004947_skin_inflammation | 1.92097033 |
| 32 | MP0002060_abnormal_skin_morphology | 1.88911656 |
| 33 | MP0002295_abnormal_pulmonary_circulatio | 1.85593963 |
| 34 | MP0009764_decreased_sensitivity_to | 1.84858248 |
| 35 | MP0000750_abnormal_muscle_regeneration | 1.80800849 |
| 36 | MP0006082_CNS_inflammation | 1.80603849 |
| 37 | MP0002877_abnormal_melanocyte_morpholog | 1.80588003 |
| 38 | MP0009278_abnormal_bone_marrow | 1.70223211 |
| 39 | MP0005166_decreased_susceptibility_to | 1.69269142 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.66827484 |
| 41 | MP0009785_altered_susceptibility_to | 1.66733461 |
| 42 | MP0005508_abnormal_skeleton_morphology | 1.66097300 |
| 43 | MP0003724_increased_susceptibility_to | 1.64949876 |
| 44 | MP0003950_abnormal_plasma_membrane | 1.64177337 |
| 45 | MP0010030_abnormal_orbit_morphology | 1.59942992 |
| 46 | MP0009250_abnormal_appendicular_skeleto | 1.52287454 |
| 47 | MP0005164_abnormal_response_to | 1.50893718 |
| 48 | MP0002796_impaired_skin_barrier | 1.50648486 |
| 49 | MP0000762_abnormal_tongue_morphology | 1.47091104 |
| 50 | MP0004883_abnormal_blood_vessel | 1.46253253 |
| 51 | MP0004484_altered_response_of | 1.46227601 |
| 52 | MP0000767_abnormal_smooth_muscle | 1.45600871 |
| 53 | MP0005595_abnormal_vascular_smooth | 1.39866054 |
| 54 | MP0000383_abnormal_hair_follicle | 1.36637533 |
| 55 | MP0003453_abnormal_keratinocyte_physiol | 1.36016859 |
| 56 | MP0002282_abnormal_trachea_morphology | 1.35133658 |
| 57 | MP0000604_amyloidosis | 1.34845383 |
| 58 | MP0001851_eye_inflammation | 1.34673733 |
| 59 | MP0002896_abnormal_bone_mineralization | 1.32780792 |
| 60 | MP0005451_abnormal_body_composition | 1.32322976 |
| 61 | MP0005000_abnormal_immune_tolerance | 1.31987536 |
| 62 | MP0005084_abnormal_gallbladder_morpholo | 1.28780776 |
| 63 | MP0003385_abnormal_body_wall | 1.28532951 |
| 64 | MP0005257_abnormal_intraocular_pressure | 1.28397269 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.27518021 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 1.27265634 |
| 67 | MP0005025_abnormal_response_to | 1.27259519 |
| 68 | MP0005390_skeleton_phenotype | 1.25886439 |
| 69 | MP0005464_abnormal_platelet_physiology | 1.25604704 |
| 70 | MP0005165_increased_susceptibility_to | 1.21601406 |
| 71 | MP0000733_abnormal_muscle_development | 1.19653682 |
| 72 | MP0004084_abnormal_cardiac_muscle | 1.19464092 |
| 73 | MP0008260_abnormal_autophagy | 1.19217670 |
| 74 | MP0001853_heart_inflammation | 1.19014106 |
| 75 | MP0001243_abnormal_dermal_layer | 1.18994516 |
| 76 | MP0003045_fibrosis | 1.18238975 |
| 77 | MP0002452_abnormal_antigen_presenting | 1.18238669 |
| 78 | MP0009053_abnormal_anal_canal | 1.18041272 |
| 79 | MP0003448_altered_tumor_morphology | 1.16084520 |
| 80 | MP0010678_abnormal_skin_adnexa | 1.15384454 |
| 81 | MP0000013_abnormal_adipose_tissue | 1.12716686 |
| 82 | * MP0000163_abnormal_cartilage_morphology | 1.11544411 |
| 83 | MP0005501_abnormal_skin_physiology | 1.11243972 |
| 84 | MP0002933_joint_inflammation | 1.10878712 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 1.10667279 |
| 86 | MP0001849_ear_inflammation | 1.10343364 |
| 87 | MP0000516_abnormal_urinary_system | 1.09988589 |
| 88 | MP0005367_renal/urinary_system_phenotyp | 1.09988589 |
| 89 | MP0002254_reproductive_system_inflammat | 1.09846901 |
| 90 | MP0001545_abnormal_hematopoietic_system | 1.09707394 |
| 91 | MP0005397_hematopoietic_system_phenotyp | 1.09707394 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 1.09321237 |
| 93 | MP0000858_altered_metastatic_potential | 1.08841259 |
| 94 | MP0003303_peritoneal_inflammation | 1.08105055 |
| 95 | MP0004233_abnormal_muscle_weight | 1.07554979 |
| 96 | MP0000343_altered_response_to | 1.07338165 |
| 97 | MP0001533_abnormal_skeleton_physiology | 1.07180611 |
| 98 | MP0008775_abnormal_heart_ventricle | 1.05549831 |
| 99 | MP0000751_myopathy | 1.05479123 |
| 100 | MP0010771_integument_phenotype | 1.03827617 |
| 101 | MP0002925_abnormal_cardiovascular_devel | 1.03000192 |
| 102 | MP0003329_amyloid_beta_deposits | 1.02797524 |
| 103 | MP0000537_abnormal_urethra_morphology | 1.02532496 |
| 104 | MP0006138_congestive_heart_failure | 1.01801899 |
| 105 | MP0002405_respiratory_system_inflammati | 1.00640328 |
| 106 | MP0001790_abnormal_immune_system | 0.99895315 |
| 107 | MP0005387_immune_system_phenotype | 0.99895315 |
| 108 | MP0001845_abnormal_inflammatory_respons | 0.99869146 |
| 109 | MP0000249_abnormal_blood_vessel | 0.99645802 |
| 110 | MP0003755_abnormal_palate_morphology | 0.97961936 |
| 111 | * MP0001614_abnormal_blood_vessel | 0.97903050 |
| 112 | MP0001299_abnormal_eye_distance/ | 0.97040574 |
| 113 | MP0002113_abnormal_skeleton_development | 0.96007048 |
| 114 | MP0003300_gastrointestinal_ulcer | 0.95821000 |
| 115 | MP0002723_abnormal_immune_serum | 0.95150946 |
| 116 | MP0008469_abnormal_protein_level | 0.94203147 |
| 117 | MP0000467_abnormal_esophagus_morphology | 0.93914316 |
| 118 | MP0005388_respiratory_system_phenotype | 0.93865985 |
| 119 | MP0002133_abnormal_respiratory_system | 0.93865985 |
| 120 | MP0002128_abnormal_blood_circulation | 0.91501483 |
| 121 | MP0002998_abnormal_bone_remodeling | 0.90355603 |
| 122 | MP0000627_abnormal_mammary_gland | 0.89961241 |
| 123 | MP0000747_muscle_weakness | 0.89744296 |
| 124 | * MP0001216_abnormal_epidermal_layer | 0.89209488 |
| 125 | MP0005167_abnormal_blood-brain_barrier | 0.86348092 |
| 126 | MP0005248_abnormal_Harderian_gland | 0.84713322 |
| 127 | * MP0002972_abnormal_cardiac_muscle | 0.84407890 |
| 128 | MP0002098_abnormal_vibrissa_morphology | 0.83802632 |
| 129 | MP0002115_abnormal_skeleton_extremities | 0.83441857 |
| 130 | MP0002108_abnormal_muscle_morphology | 0.83135947 |
| 131 | MP0003942_abnormal_urinary_system | 0.82315807 |
| 132 | MP0002420_abnormal_adaptive_immunity | 0.80252146 |
| 133 | MP0009780_abnormal_chondrocyte_physiolo | 0.80066047 |
| 134 | MP0003283_abnormal_digestive_organ | 0.79819592 |
| 135 | MP0001835_abnormal_antigen_presentation | 0.79590411 |
| 136 | MP0000432_abnormal_head_morphology | 0.78850030 |
| 137 | MP0001819_abnormal_immune_cell | 0.78478908 |
| 138 | MP0002089_abnormal_postnatal_growth/wei | 0.76759907 |
| 139 | MP0003795_abnormal_bone_structure | 0.72934143 |
| 140 | MP0004782_abnormal_surfactant_physiolog | 0.72758194 |
| 141 | MP0000049_abnormal_middle_ear | 0.72599501 |
| 142 | MP0000749_muscle_degeneration | 0.70762498 |
| 143 | MP0005076_abnormal_cell_differentiation | 0.67625099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 6.18283282 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 5.45111827 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.45111827 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.45111827 |
| 5 | Protrusio acetabuli (HP:0003179) | 5.26681037 |
| 6 | Atrophic scars (HP:0001075) | 5.21301153 |
| 7 | Amyloidosis (HP:0011034) | 4.13675609 |
| 8 | Axonal loss (HP:0003447) | 3.80328658 |
| 9 | Fragile skin (HP:0001030) | 3.68091919 |
| 10 | Shallow orbits (HP:0000586) | 3.60884542 |
| 11 | Aortic dissection (HP:0002647) | 3.51329517 |
| 12 | Interstitial pulmonary disease (HP:0006530) | 3.45340558 |
| 13 | Abnormality of macrophages (HP:0004311) | 3.40860983 |
| 14 | Myocardial infarction (HP:0001658) | 3.39843421 |
| 15 | Increased connective tissue (HP:0009025) | 3.38738072 |
| 16 | Aortic aneurysm (HP:0004942) | 3.28948067 |
| 17 | Neurofibrillary tangles (HP:0002185) | 3.27328611 |
| 18 | Dysostosis multiplex (HP:0000943) | 3.27053194 |
| 19 | Spinal rigidity (HP:0003306) | 3.26758921 |
| 20 | Increased cerebral lipofuscin (HP:0011813) | 3.24582962 |
| 21 | Distal lower limb muscle weakness (HP:0009053) | 3.23287425 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.15633654 |
| 23 | Cervical subluxation (HP:0003308) | 3.14998282 |
| 24 | Neonatal short-limb short stature (HP:0008921) | 3.14648519 |
| 25 | Milia (HP:0001056) | 3.10011086 |
| 26 | Right ventricular cardiomyopathy (HP:0011663) | 3.07514230 |
| 27 | Short nail (HP:0001799) | 3.05914967 |
| 28 | Aplasia involving bones of the extremities (HP:0009825) | 2.93248181 |
| 29 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.93248181 |
| 30 | Aplasia of the phalanges of the hand (HP:0009802) | 2.93248181 |
| 31 | Epiphyseal dysplasia (HP:0002656) | 2.93089276 |
| 32 | Onycholysis (HP:0001806) | 2.92303662 |
| 33 | Tetraparesis (HP:0002273) | 2.87206777 |
| 34 | Vascular tortuosity (HP:0004948) | 2.86038247 |
| 35 | Dilatation of the ascending aorta (HP:0005111) | 2.83665966 |
| 36 | Peritonitis (HP:0002586) | 2.82661121 |
| 37 | Asymmetric septal hypertrophy (HP:0001670) | 2.81182276 |
| 38 | Cerebral aneurysm (HP:0004944) | 2.79738561 |
| 39 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.75848011 |
| 40 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.75848011 |
| 41 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.75848011 |
| 42 | Soft skin (HP:0000977) | 2.71295114 |
| 43 | Loss of speech (HP:0002371) | 2.70133034 |
| 44 | Distal lower limb amyotrophy (HP:0008944) | 2.66558898 |
| 45 | Difficulty climbing stairs (HP:0003551) | 2.63927750 |
| 46 | Mucopolysacchariduria (HP:0008155) | 2.62771066 |
| 47 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.62771066 |
| 48 | Wormian bones (HP:0002645) | 2.62207365 |
| 49 | Abnormality of dentin (HP:0010299) | 2.59885749 |
| 50 | Spondylolisthesis (HP:0003302) | 2.59287259 |
| 51 | Muscle fiber splitting (HP:0003555) | 2.56330242 |
| 52 | Fragile nails (HP:0001808) | 2.55128930 |
| 53 | Bronchomalacia (HP:0002780) | 2.53346331 |
| 54 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.48212286 |
| 55 | Abnormality of nail color (HP:0100643) | 2.47743637 |
| 56 | Cupped ribs (HP:0000887) | 2.47534258 |
| 57 | Round ear (HP:0100830) | 2.44308104 |
| 58 | Muscle fiber inclusion bodies (HP:0100299) | 2.40249693 |
| 59 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.38476678 |
| 60 | Recurrent bacterial skin infections (HP:0005406) | 2.37743358 |
| 61 | Cerebral inclusion bodies (HP:0100314) | 2.37549741 |
| 62 | Overgrowth (HP:0001548) | 2.32201278 |
| 63 | Nemaline bodies (HP:0003798) | 2.31916315 |
| 64 | Anhidrosis (HP:0000970) | 2.31562554 |
| 65 | Systemic lupus erythematosus (HP:0002725) | 2.29665429 |
| 66 | Abnormal vertebral ossification (HP:0100569) | 2.28778530 |
| 67 | Vertebral compression fractures (HP:0002953) | 2.27982970 |
| 68 | Neuronal loss in central nervous system (HP:0002529) | 2.23814074 |
| 69 | Flat acetabular roof (HP:0003180) | 2.22984345 |
| 70 | Increased density of long bones (HP:0006392) | 2.21395786 |
| 71 | Arterial tortuosity (HP:0005116) | 2.20400586 |
| 72 | Alopecia of scalp (HP:0002293) | 2.19879814 |
| 73 | Genu recurvatum (HP:0002816) | 2.18530280 |
| 74 | Mitral valve prolapse (HP:0001634) | 2.17794189 |
| 75 | Nuclear cataract (HP:0100018) | 2.16944626 |
| 76 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.16738080 |
| 77 | Vertebral hypoplasia (HP:0008417) | 2.16738080 |
| 78 | Mutism (HP:0002300) | 2.15890843 |
| 79 | Wrist flexion contracture (HP:0001239) | 2.15793229 |
| 80 | Broad face (HP:0000283) | 2.15539215 |
| 81 | Recurrent abscess formation (HP:0002722) | 2.14338107 |
| 82 | Coxa vara (HP:0002812) | 2.13814376 |
| 83 | Hypoplastic ischia (HP:0003175) | 2.12922204 |
| 84 | Blue sclerae (HP:0000592) | 2.12559043 |
| 85 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.11008016 |
| 86 | Broad metatarsal (HP:0001783) | 2.10015415 |
| 87 | Abnormality of the 2nd finger (HP:0004100) | 2.09869751 |
| 88 | Mitral regurgitation (HP:0001653) | 2.08859989 |
| 89 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.08113071 |
| 90 | Abnormal hemoglobin (HP:0011902) | 2.07451222 |
| 91 | Apathy (HP:0000741) | 2.05479429 |
| 92 | Bladder diverticulum (HP:0000015) | 2.04805201 |
| 93 | Spinal cord compression (HP:0002176) | 2.04492423 |
| 94 | Fused cervical vertebrae (HP:0002949) | 2.04333353 |
| 95 | Thin bony cortex (HP:0002753) | 2.04179235 |
| 96 | Hyporeflexia of lower limbs (HP:0002600) | 2.02840306 |
| 97 | Short hallux (HP:0010109) | 2.02702876 |
| 98 | Xerostomia (HP:0000217) | 2.02389710 |
| 99 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.00291990 |
| 100 | Diminished motivation (HP:0000745) | 1.99304092 |
| 101 | Elbow flexion contracture (HP:0002987) | 1.98404295 |
| 102 | Thick nail (HP:0001805) | 1.95704067 |
| 103 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.95422137 |
| 104 | Disinhibition (HP:0000734) | 1.94836088 |
| 105 | Tibial bowing (HP:0002982) | 1.94656516 |
| 106 | Lower limb amyotrophy (HP:0007210) | 1.94645080 |
| 107 | Scapular winging (HP:0003691) | 1.94034795 |
| 108 | EMG: myopathic abnormalities (HP:0003458) | 1.93587271 |
| 109 | Pterygium (HP:0001059) | 1.93376196 |
| 110 | Radial bowing (HP:0002986) | 1.92495576 |
| 111 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.92479563 |
| 112 | Upper motor neuron abnormality (HP:0002127) | 1.92056467 |
| 113 | Eczematoid dermatitis (HP:0000976) | 1.91304275 |
| 114 | Ankle contracture (HP:0006466) | 1.91240777 |
| 115 | Joint stiffness (HP:0001387) | 1.89777527 |
| 116 | Vitreoretinal degeneration (HP:0000655) | 1.88435324 |
| 117 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.87692714 |
| 118 | Abnormality of the calcaneus (HP:0008364) | 1.87436388 |
| 119 | Achilles tendon contracture (HP:0001771) | 1.86505373 |
| 120 | Polygenic inheritance (HP:0010982) | 1.86291666 |
| 121 | Upper limb muscle weakness (HP:0003484) | 1.86161661 |
| 122 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.85427659 |
| 123 | Down-sloping shoulders (HP:0200021) | 1.84927234 |
| 124 | Natal tooth (HP:0000695) | 1.84736195 |
| 125 | Abnormality of the nasal septum (HP:0000419) | 1.82944622 |
| 126 | Supranuclear gaze palsy (HP:0000605) | 1.82236737 |
| 127 | Hematochezia (HP:0002573) | 1.80925217 |
| 128 | Ectopia lentis (HP:0001083) | 1.80855569 |
| 129 | Acanthosis nigricans (HP:0000956) | 1.80524690 |
| 130 | Glossoptosis (HP:0000162) | 1.80338435 |
| 131 | Congenital, generalized hypertrichosis (HP:0004540) | 1.78932410 |
| 132 | Follicular hyperkeratosis (HP:0007502) | 1.78644159 |
| 133 | Exercise-induced myalgia (HP:0003738) | 1.78592687 |
| 134 | Abnormality of the acetabulum (HP:0003170) | 1.78392653 |
| 135 | Vascular calcification (HP:0004934) | 1.77498902 |
| 136 | Plantar hyperkeratosis (HP:0007556) | 1.77474874 |
| 137 | Cardiovascular calcification (HP:0011915) | 1.77137770 |
| 138 | Stomatitis (HP:0010280) | 1.77042542 |
| 139 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.76964361 |
| 140 | Hyperextensible skin (HP:0000974) | 1.76909361 |
| 141 | Abnormal blistering of the skin (HP:0008066) | 1.76873347 |
| 142 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.76653134 |
| 143 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.76184236 |
| 144 | Abnormality of the ischium (HP:0003174) | 1.76051322 |
| 145 | Mediastinal lymphadenopathy (HP:0100721) | 1.75697026 |
| 146 | Bone cyst (HP:0012062) | 1.75187167 |
| 147 | Abnormality of the umbilical cord (HP:0010881) | 1.74729964 |
| 148 | Limb-girdle muscle atrophy (HP:0003797) | 1.74282760 |
| 149 | Trismus (HP:0000211) | 1.73733991 |
| 150 | Increased serum ferritin (HP:0003281) | 1.72996362 |
| 151 | Osteolytic defects of the hand bones (HP:0009699) | 1.71328034 |
| 152 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.71328034 |
| 153 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.71259020 |
| 154 | Camptodactyly of toe (HP:0001836) | 1.71256890 |
| 155 | Malnutrition (HP:0004395) | 1.71247683 |
| 156 | Mesangial abnormality (HP:0001966) | 1.71049876 |
| 157 | Upper limb amyotrophy (HP:0009129) | 1.70700121 |
| 158 | Distal upper limb amyotrophy (HP:0007149) | 1.70700121 |
| 159 | Coronal craniosynostosis (HP:0004440) | 1.70442324 |
| 160 | Stillbirth (HP:0003826) | 1.70303954 |
| 161 | Aneurysm (HP:0002617) | 1.70269326 |
| 162 | Increased CSF protein (HP:0002922) | 1.70162853 |
| 163 | Nail dystrophy (HP:0008404) | 1.69981991 |
| 164 | Autoimmune thrombocytopenia (HP:0001973) | 1.69908215 |
| 165 | Ileus (HP:0002595) | 1.69678413 |
| 166 | Aortic valve stenosis (HP:0001650) | 1.69140004 |
| 167 | Palmoplantar hyperkeratosis (HP:0000972) | 1.67350903 |
| 168 | Fatigue (HP:0012378) | 1.66593500 |
| 169 | Progressive neurologic deterioration (HP:0002344) | 1.61844526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 6.23033459 |
| 2 | MAP3K3 | 3.92516550 |
| 3 | PIM2 | 2.75402697 |
| 4 | BLK | 2.74796185 |
| 5 | EPHB2 | 2.59885640 |
| 6 | TIE1 | 2.51809934 |
| 7 | MST4 | 2.51504090 |
| 8 | DDR2 | 2.39439120 |
| 9 | TTN | 2.38097713 |
| 10 | ARAF | 2.33095993 |
| 11 | TESK1 | 2.23403035 |
| 12 | FER | 2.11178439 |
| 13 | TRPM7 | 2.05571597 |
| 14 | PAK2 | 1.99614098 |
| 15 | RIPK1 | 1.97312388 |
| 16 | PRPF4B | 1.93441906 |
| 17 | LATS2 | 1.92680412 |
| 18 | LIMK1 | 1.87039603 |
| 19 | TGFBR2 | 1.81997817 |
| 20 | MAPK15 | 1.77081533 |
| 21 | LATS1 | 1.70543477 |
| 22 | TAOK1 | 1.67828687 |
| 23 | PRKG2 | 1.66461137 |
| 24 | MAP2K2 | 1.60899853 |
| 25 | PIK3CG | 1.58490682 |
| 26 | MAP3K13 | 1.58331974 |
| 27 | ERBB3 | 1.57550163 |
| 28 | MAP3K11 | 1.54935897 |
| 29 | PTK2 | 1.53661970 |
| 30 | MYLK | 1.52013644 |
| 31 | PIK3CA | 1.48413336 |
| 32 | STK10 | 1.46765707 |
| 33 | MOS | 1.44069683 |
| 34 | TAOK2 | 1.43419754 |
| 35 | DMPK | 1.41139691 |
| 36 | LRRK2 | 1.38119269 |
| 37 | MST1R | 1.37756056 |
| 38 | ERN1 | 1.37240602 |
| 39 | ZAP70 | 1.32323314 |
| 40 | TESK2 | 1.27650215 |
| 41 | PDGFRA | 1.25378375 |
| 42 | BMX | 1.24209879 |
| 43 | MAP3K9 | 1.22980025 |
| 44 | STK38L | 1.22756468 |
| 45 | STK24 | 1.22320849 |
| 46 | MAP2K3 | 1.21125990 |
| 47 | TRIB3 | 1.18929005 |
| 48 | MET | 1.16570638 |
| 49 | KDR | 1.16101023 |
| 50 | PAK3 | 1.11741305 |
| 51 | MAPK7 | 1.11351082 |
| 52 | RPS6KB2 | 1.07830094 |
| 53 | NUAK1 | 1.06219399 |
| 54 | BMPR2 | 1.03462589 |
| 55 | PTK2B | 1.03141957 |
| 56 | MAP3K1 | 1.00937426 |
| 57 | PTK6 | 0.98761602 |
| 58 | MAPK12 | 0.97725337 |
| 59 | MAPKAPK3 | 0.95188866 |
| 60 | OBSCN | 0.92180125 |
| 61 | MAP3K12 | 0.91596809 |
| 62 | TGFBR1 | 0.90116885 |
| 63 | NME2 | 0.89808074 |
| 64 | MAP2K1 | 0.88085265 |
| 65 | RPS6KA4 | 0.87703831 |
| 66 | ERBB4 | 0.87532584 |
| 67 | ROCK1 | 0.86775865 |
| 68 | FRK | 0.81817494 |
| 69 | EPHB1 | 0.80180835 |
| 70 | IRAK2 | 0.79896434 |
| 71 | CAMK1D | 0.76716160 |
| 72 | PDGFRB | 0.76014613 |
| 73 | GSK3A | 0.73879233 |
| 74 | FGR | 0.73338467 |
| 75 | EPHA3 | 0.72493402 |
| 76 | PAK4 | 0.72344312 |
| 77 | ILK | 0.71237322 |
| 78 | IRAK4 | 0.70675669 |
| 79 | RPS6KA2 | 0.67367176 |
| 80 | DAPK3 | 0.66618079 |
| 81 | PBK | 0.63856789 |
| 82 | STK3 | 0.63794680 |
| 83 | TYK2 | 0.63591891 |
| 84 | IKBKE | 0.62654820 |
| 85 | INSR | 0.62396745 |
| 86 | SIK1 | 0.62323438 |
| 87 | PDPK1 | 0.62142717 |
| 88 | LMTK2 | 0.62083953 |
| 89 | SIK3 | 0.61116783 |
| 90 | MAPKAPK5 | 0.61095697 |
| 91 | NTRK1 | 0.59075963 |
| 92 | GRK7 | 0.57949370 |
| 93 | PDK2 | 0.55628123 |
| 94 | GRK1 | 0.55470642 |
| 95 | TEC | 0.55390165 |
| 96 | RIPK4 | 0.54562317 |
| 97 | IRAK1 | 0.52312910 |
| 98 | RPS6KC1 | 0.50989882 |
| 99 | RPS6KL1 | 0.50989882 |
| 100 | MAP3K6 | 0.50433849 |
| 101 | NEK9 | 0.49992253 |
| 102 | NME1 | 0.49988347 |
| 103 | MAPK4 | 0.49768527 |
| 104 | MAPKAPK2 | 0.49662350 |
| 105 | IKBKB | 0.48196954 |
| 106 | ADRBK1 | 0.47670049 |
| 107 | MAP3K14 | 0.47333771 |
| 108 | TBK1 | 0.47225840 |
| 109 | PRKD1 | 0.46761195 |
| 110 | PKN2 | 0.44126382 |
| 111 | EGFR | 0.43621839 |
| 112 | ABL2 | 0.43092714 |
| 113 | MAP3K5 | 0.42840274 |
| 114 | PRKCE | 0.42819502 |
| 115 | CAMKK2 | 0.42698378 |
| 116 | FGFR1 | 0.42063904 |
| 117 | IRAK3 | 0.40588769 |
| 118 | MAP3K8 | 0.40122839 |
| 119 | MAP3K2 | 0.39779708 |
| 120 | PHKG2 | 0.38753042 |
| 121 | PHKG1 | 0.38753042 |
| 122 | MATK | 0.38007672 |
| 123 | CSK | 0.37921058 |
| 124 | ROCK2 | 0.37819465 |
| 125 | RPS6KA6 | 0.36712520 |
| 126 | ABL1 | 0.36267183 |
| 127 | NLK | 0.36085956 |
| 128 | CDC42BPA | 0.36084538 |
| 129 | KSR1 | 0.35237865 |
| 130 | CHUK | 0.34003228 |
| 131 | ZAK | 0.33976870 |
| 132 | PAK1 | 0.33689033 |
| 133 | PRKD2 | 0.33413869 |
| 134 | IGF1R | 0.33399873 |
| 135 | HIPK2 | 0.33218443 |
| 136 | BCR | 0.33078042 |
| 137 | EIF2AK2 | 0.32127118 |
| 138 | SRC | 0.31281581 |
| 139 | CAMK2G | 0.31063152 |
| 140 | MTOR | 0.30946390 |
| 141 | SGK3 | 0.30849909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 4.07129901 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.98451408 |
| 3 | Focal adhesion_Homo sapiens_hsa04510 | 2.73715323 |
| 4 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.57834297 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.53324660 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.44389908 |
| 7 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.37670060 |
| 8 | Adherens junction_Homo sapiens_hsa04520 | 2.28320438 |
| 9 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.27948432 |
| 10 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 2.18773356 |
| 11 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.12884225 |
| 12 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.09611517 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.06890416 |
| 14 | Hippo signaling pathway_Homo sapiens_hsa04390 | 2.06632586 |
| 15 | Small cell lung cancer_Homo sapiens_hsa05222 | 2.04382917 |
| 16 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 2.00994423 |
| 17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.99321556 |
| 18 | * Bladder cancer_Homo sapiens_hsa05219 | 1.96632063 |
| 19 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.95527580 |
| 20 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.88932917 |
| 21 | Amoebiasis_Homo sapiens_hsa05146 | 1.88495964 |
| 22 | Tight junction_Homo sapiens_hsa04530 | 1.84558333 |
| 23 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.77410026 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.67191860 |
| 25 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.66324216 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.66016851 |
| 27 | Prion diseases_Homo sapiens_hsa05020 | 1.49177417 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48012461 |
| 29 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.46403721 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.44887100 |
| 31 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.40810181 |
| 32 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.39344418 |
| 33 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.38071734 |
| 34 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.35846473 |
| 35 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.26870316 |
| 36 | Ribosome_Homo sapiens_hsa03010 | 1.25268256 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 1.22807407 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.22708024 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21878298 |
| 40 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.21347183 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.19000079 |
| 42 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.17412655 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16017065 |
| 44 | Galactose metabolism_Homo sapiens_hsa00052 | 1.11647767 |
| 45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.11015053 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.10815334 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09105591 |
| 48 | Pathways in cancer_Homo sapiens_hsa05200 | 1.04876764 |
| 49 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.04576189 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 1.04275489 |
| 51 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.04195141 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 1.02452256 |
| 53 | HTLV-I infection_Homo sapiens_hsa05166 | 1.02092550 |
| 54 | Melanoma_Homo sapiens_hsa05218 | 1.01786488 |
| 55 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.99725451 |
| 56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.96552574 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95638862 |
| 58 | Axon guidance_Homo sapiens_hsa04360 | 0.95361692 |
| 59 | Leishmaniasis_Homo sapiens_hsa05140 | 0.94659403 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.93844514 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.92553572 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 0.91686321 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 0.90893615 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87627348 |
| 65 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.86785491 |
| 66 | Melanogenesis_Homo sapiens_hsa04916 | 0.84535311 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81352648 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80814542 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80339327 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.79276882 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79007813 |
| 72 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.78851347 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75771220 |
| 74 | Prostate cancer_Homo sapiens_hsa05215 | 0.73246194 |
| 75 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73089661 |
| 76 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.73017996 |
| 77 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70635664 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69565256 |
| 79 | Gap junction_Homo sapiens_hsa04540 | 0.69355604 |
| 80 | Asthma_Homo sapiens_hsa05310 | 0.68801472 |
| 81 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68243946 |
| 82 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67343805 |
| 83 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66627700 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66181604 |
| 85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64649463 |
| 86 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64175795 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63820303 |
| 88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61627339 |
| 89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.61273970 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60834925 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60722559 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 0.60419069 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58436218 |
| 94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57096978 |
| 95 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54966428 |
| 96 | Hepatitis B_Homo sapiens_hsa05161 | 0.54796854 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53851040 |
| 98 | Measles_Homo sapiens_hsa05162 | 0.53557139 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53076249 |
| 100 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.52955495 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52828083 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.52331131 |
| 103 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.51952975 |
| 104 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.51276008 |
| 105 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.50758476 |
| 106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49821345 |
| 107 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48654363 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48269309 |
| 109 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.47282713 |
| 110 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47214486 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47167191 |
| 112 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.46929113 |
| 113 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46779614 |
| 114 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.46546993 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46268673 |
| 116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46167617 |
| 117 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46155606 |
| 118 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.45071704 |
| 119 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44633224 |
| 120 | Cocaine addiction_Homo sapiens_hsa05030 | 0.44530793 |
| 121 | Endocytosis_Homo sapiens_hsa04144 | 0.43616973 |
| 122 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42337323 |
| 123 | Legionellosis_Homo sapiens_hsa05134 | 0.41456185 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41256487 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40915383 |
| 126 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40836047 |
| 127 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40615613 |
| 128 | Protein export_Homo sapiens_hsa03060 | 0.40396781 |
| 129 | Glioma_Homo sapiens_hsa05214 | 0.39519486 |
| 130 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39062827 |
| 131 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38435471 |
| 132 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37947233 |
| 133 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37219981 |
| 134 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.35260102 |
| 135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35012303 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34905879 |

